Bessemer Group’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-111
Closed -$3K – 2743
2025
Q3
$3K Buy
+111
New +$3.01K ﹤0.01% 2274
2025
Q2
– Sell
-235
Closed -$7K – 2670
2025
Q1
$7K Buy
235
+116
+97% +$3.87K ﹤0.01% 1931
2024
Q4
$4K Hold
119
– – ﹤0.01% 2095
2024
Q3
$7K Buy
119
+45
+61% +$2.21K ﹤0.01% 1818
2024
Q2
$3K Hold
74
– – ﹤0.01% 1911
2024
Q1
$3K Sell
74
-65
-47% -$2.54K ﹤0.01% 1911
2023
Q4
$5K Buy
139
+74
+114% +$2.46K ﹤0.01% 1794
2023
Q3
$2K Sell
65
-37
-36% -$1.28K ﹤0.01% 2036
2023
Q2
$3K Buy
102
+37
+57% +$1.27K ﹤0.01% 1994
2023
Q1
$2K Hold
65
– – ﹤0.01% 1832
2022
Q4
$2K Hold
65
– – ﹤0.01% 1792
2022
Q3
$3K Hold
65
– – ﹤0.01% 1881
2022
Q2
$3K Hold
65
– – ﹤0.01% 1712
2022
Q1
$3K Hold
65
– – ﹤0.01% 1702
2021
Q4
$5K Buy
+65
New +$5.34K ﹤0.01% 1603
2020
Q3
– Sell
-30,000
Closed -$495K – 1700
2020
Q2
$495K Hold
30,000
– – ﹤0.01% 977
2020
Q1
$388K Buy
30,000
+500
+2% +$8.16K ﹤0.01% 844
2019
Q4
$543K Buy
29,500
+10,200
+53% +$169K ﹤0.01% 893
2019
Q3
$340K Buy
+19,300
New +$330K ﹤0.01% 958

Other funds holding ASTH

Bessemer Group's ASTH Position: Q4 2025 in Review

Bessemer Group sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 111 shares — an estimated $3K sold.

Bessemer Group first reported a position in ASTH in Q3 2019 and held it in 19 quarters. The position peaked at $543K in Q4 2019. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Bessemer Group reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Bessemer Group sold 111 Astrana Health shares in Q4 2025, an estimated $3K.
  • Bessemer Group first reported a position in Astrana Health in Q3 2019 and held it in 19 quarters.
  • Bessemer Group's Astrana Health position peaked at $543K in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.